Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  25 results for ""Recombinant Fusion Proteins""

Your Filters

Geographic : sweden
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway.

  • Authors : Christiansen CF; Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.; Risbo N

Subjects: Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/therapeutic use ; Thrombopoietin*/Thrombopoietin*/Thrombopoietin*/therapeutic use ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy

  • Source: British journal of haematology [Br J Haematol] 2024 Oct; Vol. 205 (4), pp. 1497-1507. Date of Electronic Publication: 2024 Aug 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden - data from the Swedish Macula Register.

  • Authors : Wickman I; Department of Ophthalmology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. .; Lövestam-Adrian M

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Wet Macular Degeneration*/Wet Macular Degeneration*/Wet Macular Degeneration*/drug therapy ; Wet Macular Degeneration*/Wet Macular Degeneration*/Wet Macular Degeneration*/epidemiology

  • Source: BMC ophthalmology [BMC Ophthalmol] 2024 Jan 30; Vol. 24 (1), pp. 49. Date of Electronic Publication: 2024 Jan 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details

Read More Add to Saved list
×
Academic Journal

Worth changing? Clinical effects of switching treatment in neovascular age-related macular degeneration from intravitreal ranibizumab and aflibercept to bevacizumab in a region in southern Sweden.

  • Authors : Bro T; The Eye Unit, Höglandssjukhuset, Eksjö, Sweden.; Futurum, Region Jönköping County, Jönköping, Sweden.

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Bevacizumab/Bevacizumab/Bevacizumab/*therapeutic use ; Choroidal Neovascularization/Choroidal Neovascularization/Choroidal Neovascularization/*drug therapy

  • Source: European journal of ophthalmology [Eur J Ophthalmol] 2021 Jan; Vol. 31 (1), pp. 144-148. Date of Electronic Publication: 2019 Oct 23.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR).

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*administration & dosage ; Bevacizumab/Bevacizumab/Bevacizumab/*administration & dosage ; Macular Degeneration/Macular Degeneration/Macular Degeneration/*drug therapy

  • Source: Acta ophthalmologica [Acta Ophthalmol] 2020 May; Vol. 98 (3), pp. 274-278. Date of Electronic Publication: 2019 Sep 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.

Subjects: Cost-Benefit Analysis*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of medical economics [J Med Econ] 2019 Oct; Vol. 22 (10), pp. 997-1005. Date of Electronic Publication: 2019 May 23.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register.

Subjects: Visual Acuity*; Macula Lutea/Macula Lutea/Macula Lutea/*pathology ; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*administration & dosage

  • Source: Acta ophthalmologica [Acta Ophthalmol] 2019 Feb; Vol. 97 (1), pp. 91-98. Date of Electronic Publication: 2018 Sep 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration.

  • Authors : Westborg I; a Department of Clinical Sciences/Ophthalmology , Umeå University , Umeå , Sweden.; Rosso A

Subjects: Withholding Treatment*; Ranibizumab/Ranibizumab/Ranibizumab/*administration & dosage ; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*administration & dosage

  • Source: Ophthalmic epidemiology [Ophthalmic Epidemiol] 2018 Apr; Vol. 25 (2), pp. 176-182. Date of Electronic Publication: 2017 Nov 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9435674 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden.

Subjects: *RECOMBINANT fusion proteins; *DIABETIC retinopathy; *EDEMASWEDEN

  • Source: Value in Health. Nov2015, Vol. 18 Issue 7, pA420-A421. 1p.

Record details

Read More Add to Saved list
×
Academic Journal

Efanesoctocog Alfa: First Approval.

Subjects: DRUG approval; HEMOPHILIA; INTERPROFESSIONAL relationsFRANCE; SWEDEN

  • Source: Drugs; May2023, Vol. 83 Issue 7, p633-638, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries.

Subjects: BLOOD coagulation factor IX; CHIMERIC proteins; BLOOD coagulation factor VIIIFINLAND; NORWAY; SWEDEN

  • Source: Haemophilia; Sep2022, Vol. 28 Issue 5, p713-719, 7p, 1 Chart, 1 Graph

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  25 results for ""Recombinant Fusion Proteins""